Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Americas

      AbbVies Showcased at Digestive Disease Week with New HUMIRA ,Real-World Research and Promising Anti-IL-23 Antibody Late-Breaking Data

      Americas
      Data presentations further evaluate HUMIRA® (adalimumab) for the treatment of inflammatory bowel diseases including moderate to severe Crohn's disease in adult and pediatric...

      Merck & Co Inc Final overall survival (OS) dataData from KEYNOTE-006 and KEYNOTE-001 in Advanced Melanoma To Be Presented at 2016 ASCO Annual Meeting

      Americas
      Final Overall Survival Data from KEYNOTE-006 To Be Presented at ASCO; KEYTRUDA, the First Anti-PD-1 Monotherapy to Demonstrate Overall Survival Compared to Ipilimumab, Shows...

      AbbVie Inc to participate at the UBS Global Health Care Conference

      Americas
      AbbVie will participate in the UBS Global Healthcare Conference on Monday, May 23, 2016. Bill Chase, executive vice president and chief financial officer, will...

      ALMAC GROUP LAUNCHES US SERIALISATION SOLUTION

      Americas
      Almac Group, the global contract development and manufacturing organisation, is pleased to announce an expansion to its serialisation capabilities to include its US commercial...

      Merck Receives Breakthrough Therapy Designation from U.S. FDA for KEYTRUDA in Classical Hodgkin Lymphoma (cHL)

      Americas
      Merck, known as MSD outside the United States and Canada, announced that the U.S. FDA has granted Breakthrough Therapy Designation to KEYTRUDA® (pembrolizumab), the...

      Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering RAVICTI(R) (glycerol phenylbutyrate) Oral...

      Americas
      Will Represent Sixth U.S. Patent to Be Listed in the Orange Book for RAVICTI Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused...

      Unilateral Pricing Policy

      Americas
      Alcon’s limited unilateral pricing policy applies only to new and innovative brands of contact lens and was introduced to encourage eye care professionals...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.